glp 1 mimetics Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss GLP-1 receptor agonists | How

DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects

*Correspondence: Arjola Bano, [email protected] These authors have contributed equally to this work This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Frontiers in Endocrinology, 15

However, when a third of the participants were switched to a placebo for the following year, they regained 7% of the weight they had lost

Immunohistochemical studies in monkeys and humans found GLP-1R+ cells mainly in the sinoatrial node and atrial tissue, with higher expression in the right atrium